SCHEMBL18954792

SCHEMBL18954792

CCOC(=O)C(C)N1C(=O)C(=O)c2cc(Br)cc(Br)c21

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PARK7 Q99497 4/20 0.44
SMAD3 P84022 2/20 0.39
APAF1 O14727 1/20 0.39
MAPT P10636 5/20 0.38
TP53 P04637 2/20 0.38
KDM1A O60341 1/20 0.37
ALDH1A1 P00352 9/20 0.37
HSD17B10 Q99714 2/20 0.37
HTT P42858 1/20 0.37
ALDH2 P05091 4/20 0.37
ALDH3A1 P30838 4/20 0.37
ESR1 P03372 1/20 0.36
LMNA P02545 1/20 0.34
MEN1 O00255 1/20 0.34
MAPK1 P28482 1/20 0.34
KMT2A Q03164 1/20 0.34
USP2 O75604 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18954640 0.85 ALDH1A1 (0.48) SMAD3APAF1MAPTTP53ALDH1A1
SCHEMBL18954632 0.82 PARK7 (0.43) PARK7MAPTTP53ALDH1A1HSD17B10
SCHEMBL18954643 0.77 SMAD3 (0.44) SMAD3APAF1MAPTKDM1AALDH1A1
SCHEMBL18954621 0.77 ALDH1A1 (0.40) MAPTTP53ALDH1A1HSD17B10HTT
SCHEMBL18954756 0.77 KMT2A (0.40) MAPTTP53ALDH1A1HSD17B10HTT
SCHEMBL18954673 0.76 ALDH1A1 (0.60) MAPTTP53ALDH1A1HSD17B10HTT
SCHEMBL9179332 0.75 ALDH1A1 (0.62) PARK7MAPTTP53ALDH1A1HSD17B10
SCHEMBL18954512 0.74 ALDH1A1 (0.48) MAPTTP53ALDH1A1HSD17B10HTT
SCHEMBL18955259 0.73 ALDH1A1 (0.47) MAPTTP53ALDH1A1HSD17B10HTT
SCHEMBL18954746 0.73 PARK7 (0.52) PARK7MAPTTP53ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017099695-A1 N-[(AMINOSULFONYL)PHENYL]-2-(1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)-HYDRAZINECARBOTHIOAMIDE DERIVATIVES FOR TREATING CANCER AND IMMUNOLOGICAL DISORDERS ISTANBUL UNIVERSITESI REKTORLUGU (TR) 2017-06-15 WO disclosed
US-9150556-B2 Benzimidazolone chymase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-10-06 US disclosed